Clinical Trial Update: Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of tenofovir disoproxil fumarate on lipid levels in HIV-infected adults on stable antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• HIV Infection
• Hypercholesterolemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Dyslipidemia | NA | Status: COMPLETED